Rexulti Full Prescribing Information, Dosage & Side Effects

FDA's Fast-Track for Rexulti Raises Concerns

REXULTI® (brexpiprazole) Patient Information Website

Rexulti (Brexpiprazole) - PSYCH-MENTAL HEALTH HUB

Rexulti 1 mg 28 tablets

Rexulti 4 mg 28 tablets

Brexpiprazole for schizophrenia and as adjunct for major depressive disorder

FDA chides Otsuka for making false or misleading claims in Rexulti advertising

How Marketers Accentuate Clinical Messaging

New Drug Product: REXULTI - MPR

Otsuka and Lundbeck Announce U.S. Food and Drug Administration (FDA) Approval of Supplemental New Drug Application (sNDA) for REXULTI® (brexpiprazole) for the Treatment of Agitation Associated with Dementia Due to Alzheimer's Disease